Ferring enters into worldwide OmniAb® platform license agreement with Ligand
Ferring Pharmaceuticals will use Ligand』s OmniAb® platform to discover new human monoclonal antibodies Through this platform, Ferring aims to accelerate development solutions for unmet pat......